Yuyin Liu
AstraZeneca (United States)(US)Affiliated Hospital of Shandong University of Traditional Chinese Medicine(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Antiplatelet Therapy and Cardiovascular Diseases, Diabetes Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial(2021)353 cited
- → Ticagrelor in Patients with Stable Coronary Disease and Diabetes(2019)352 cited
- → Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US(2021)212 cited
- → Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography(2016)126 cited
- → Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease(2019)124 cited
- → Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives(2023)124 cited